NCT06409832Recruiting
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 5 Apr 2024
- Start date
- 26 Mar 2024
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- University of Florence
- Diseases
- Migraine
- NCT number
- NCT06409832
What you commit to
- Study type: Observational
- Planned participants: 100
- From 26 Mar 2024 to the primary completion date, 1 Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments;
- Changes in preventive treatments in the month before the first administration of rimegepant
Other
- Subjects with contraindications for use of gepants;
- Diagnosis of chronic migraine
- medical comorbidities that could interfere with study results;
- Pregnancy and breastfeeding.
Who the study is looking for
- Diagnosis of migraine without aura or migraine with aura, according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
- At least 4 monthly migraine days;
- Good compliance to study procedures;
- Availability of headache diary at least of the preceding months before enrollment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi Coordinator of this site? Confirm its status | Florence | Italy | Recruiting |
| IRCCS National Neurological Institute "C. Mondino" Foundation Coordinator of this site? Confirm its status | Pavia | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.